Former Bioverativ Inc. board member Alexander J. Denner and the activist hedge fund he controlled must face insider trading claims in a Delaware Chancery Court lawsuit alleging an unfair deal process behind the company's $11.6 billion sale to Sanofi in 2018.
05.01.2022 - SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) - Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and . Seite 1
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare